Phigenix, Inc. v. Genentech, Inc. > Summary
Court Case Number 5:15-cv-01238
Filing Date Mar 17, 2015
Court California Northern District Court
Status Unknown
Appeal2017-2617
Defendant
Plaintiff Attorneys
11Phigenix
Attorney Name: Paul D. Ackerman
Hunton Andrews Kurth
Phigenix
Attorney Name: Robert Alan Gutkin
Hunton Andrews Kurth
MUSC Foundation for Research Development
Attorney Name: David C. Hanson
The Weathington Firm Attorneys At Law
Phigenix
Attorney Name: David C. Hanson
The Weathington Firm Attorneys At Law
Phigenix
Attorney Name: Edward Vincent King Jr.
King & Kelleher
Phigenix
Attorney Name: Aldo Noto
Hunton Andrews Kurth
Phigenix
Attorney Name: Gregory Lawrence Porter
Hunton Andrews Kurth
Phigenix
Attorney Name: Ping Wang
Hunton Andrews Kurth
Phigenix
Attorney Name: Paul E. Weathington
The Weathington Firm Attorneys At Law
MUSC Foundation for Research Development
Attorney Name: Paul E. Weathington
The Weathington Firm Attorneys At Law
Phigenix
Attorney Name: Michael Ye
Hunton Andrews Kurth
Defendant Attorneys
13Genentech, Inc
Attorney Name: John Knowles Blake Jr.
Morrison & Foerster
Genentech, Inc
Attorney Name: James J. Cekola
Morrison & Foerster
Genentech, Inc
Attorney Name: Matthew A. Chivvis
Morrison & Foerster
Genentech, Inc
Attorney Name: George C. Harris
Morrison & Foerster
Genentech, Inc
Attorney Name: Matthew I. Kreeger
Morrison & Foerster
Genentech, Inc
Attorney Name: Xiang Li
Morrison & Foerster
Genentech, Inc
Attorney Name: Frank M. Lowrey IV
Bondurant Mixson & Elmore, LLP
Genentech, Inc
Attorney Name: Tiana Scogin Mykkeltvedt
Bondurant Mixson & Elmore, LLP
Genentech, Inc
Attorney Name: Catherine Mary Polizzi
Morrison & Foerster
Genentech, Inc
Attorney Name: Randi Engel Schnell
Bondurant Mixson & Elmore, LLP
Genentech, Inc
Attorney Name: Christopher J. Wiener
Morrison & Foerster
Genentech, Inc
Attorney Name: Michael A. Jacobs
Morrison & Foerster
Attorney Name: John Knowles Blake Jr.
Cause
28:1338 Patent Infringement
Related Patents
Doc No | Title | Issue date |
---|---|---|
08080534 | Targeting PAX2 for the treatment of breast cancer | Dec 20, 2011 |